Yale University Digestive Diseases — New Haven, Connecticut

Yale University Digestive Diseases is a clinical research site located in New Haven, Connecticut, United States 06520.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Yale University Digestive Diseases has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Hepatitis B, Hepatitis, Liver Diseases.

Sponsors: Target PharmaSolutions, Inc., Romark Laboratories L.C., University of North Carolina, Chapel Hill.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale University Digestive Diseases?

Yale University Digestive Diseases has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale University Digestive Diseases conducted?

Yale University Digestive Diseases has 5 clinical trials on record, with 1 currently active. Their work covers Hepatitis B, Hepatitis, Liver Diseases.

Is Yale University Digestive Diseases accredited by Crixeo Health?

Yes — Yale University Digestive Diseases holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Yale University Digestive Diseases?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.